202 related articles for article (PubMed ID: 27838491)
21. Aminolevulinate synthase: lysine 313 is not essential for binding the pyridoxal phosphate cofactor but is essential for catalysis.
Ferreira GC; Vajapey U; Hafez O; Hunter GA; Barber MJ
Protein Sci; 1995 May; 4(5):1001-6. PubMed ID: 7663334
[TBL] [Abstract][Full Text] [Related]
22. 5-Aminolevulinate synthase and the first step of heme biosynthesis.
Ferreira GC; Gong J
J Bioenerg Biomembr; 1995 Apr; 27(2):151-9. PubMed ID: 7592562
[TBL] [Abstract][Full Text] [Related]
23. Mechanism of 5-aminolevulinate synthase and the role of the protein environment in controlling the cofactor chemistry.
Ferreira GC; Zhang JS
Cell Mol Biol (Noisy-le-grand); 2002 Dec; 48(8):827-33. PubMed ID: 12699240
[TBL] [Abstract][Full Text] [Related]
24. Murine erythroid 5-aminolevulinate synthase: Truncation of a disordered N-terminal extension is not detrimental for catalysis.
Stojanovski BM; Breydo L; Uversky VN; Ferreira GC
Biochim Biophys Acta; 2016 May; 1864(5):441-52. PubMed ID: 26854603
[TBL] [Abstract][Full Text] [Related]
25. Bone marrow delta-aminolaevulinate synthase deficiency in a female with congenital sideroblastic anemia.
Buchanan GR; Bottomley SS; Nitschke R
Blood; 1980 Jan; 55(1):109-15. PubMed ID: 7350930
[TBL] [Abstract][Full Text] [Related]
26. Circular permutation of 5-aminolevulinate synthase as a tool to evaluate folding, structure and function.
Ferreira GC; Cheltsov AV
Cell Mol Biol (Noisy-le-grand); 2002 Feb; 48(1):11-6. PubMed ID: 11929042
[TBL] [Abstract][Full Text] [Related]
27. Molecular enzymology of 5-aminolevulinate synthase, the gatekeeper of heme biosynthesis.
Hunter GA; Ferreira GC
Biochim Biophys Acta; 2011 Nov; 1814(11):1467-73. PubMed ID: 21215825
[TBL] [Abstract][Full Text] [Related]
28. X-linked sideroblastic anaemia due to ALAS₂ mutations in the Netherlands: a disease in disguise.
Donker AE; Raymakers RA; Nieuwenhuis HK; Coenen MJ; Janssen MC; MacKenzie MA; Brons PP; Swinkels DW
Neth J Med; 2014 May; 72(4):210-7. PubMed ID: 24829177
[TBL] [Abstract][Full Text] [Related]
29. Haema synthesis during pyridoxine therapy in two families with different types of hereditary sideroblastic anaemia.
Pasanen AV; Salmi M; Tenhunen R; Vuopio P
Ann Clin Res; 1982 Apr; 14(2):61-5. PubMed ID: 7149613
[TBL] [Abstract][Full Text] [Related]
30. A promoter mutation in the erythroid-specific 5-aminolevulinate synthase (ALAS2) gene causes X-linked sideroblastic anemia.
Bekri S; May A; Cotter PD; Al-Sabah AI; Guo X; Masters GS; Bishop DF
Blood; 2003 Jul; 102(2):698-704. PubMed ID: 12663458
[TBL] [Abstract][Full Text] [Related]
31. Haem synthesis in sideroblastic anaemia.
Konopka L; Hoffbrand AV
Br J Haematol; 1979 May; 42(1):73-83. PubMed ID: 465361
[TBL] [Abstract][Full Text] [Related]
32. The Isoniazid Metabolites Hydrazine and Pyridoxal Isonicotinoyl Hydrazone Modulate Heme Biosynthesis.
Brewer CT; Yang L; Edwards A; Lu Y; Low J; Wu J; Lee RE; Chen T
Toxicol Sci; 2019 Mar; 168(1):209-224. PubMed ID: 30517741
[TBL] [Abstract][Full Text] [Related]
33. R411C mutation of the ALAS2 gene encodes a pyridoxine-responsive enzyme with low activity.
Furuyama K; Uno R; Urabe A; Hayashi N; Fujita H; Kondo M; Sassa S; Yamamoto M
Br J Haematol; 1998 Dec; 103(3):839-41. PubMed ID: 9858242
[TBL] [Abstract][Full Text] [Related]
34. Mutation in human
Yien YY; Ducamp S; van der Vorm LN; Kardon JR; Manceau H; Kannengiesser C; Bergonia HA; Kafina MD; Karim Z; Gouya L; Baker TA; Puy H; Phillips JD; Nicolas G; Paw BH
Proc Natl Acad Sci U S A; 2017 Sep; 114(38):E8045-E8052. PubMed ID: 28874591
[TBL] [Abstract][Full Text] [Related]
35. New mutation in erythroid-specific delta-aminolevulinate synthase as the cause of X-linked sideroblastic anemia responsive to pyridoxine.
Kucerova J; Horvathova M; Mojzikova R; Belohlavkova P; Cermak J; Divoky V
Acta Haematol; 2011; 125(4):193-7. PubMed ID: 21252495
[TBL] [Abstract][Full Text] [Related]
36. Heme biosynthesis in mammalian systems: evidence of a Schiff base linkage between the pyridoxal 5'-phosphate cofactor and a lysine residue in 5-aminolevulinate synthase.
Ferreira GC; Neame PJ; Dailey HA
Protein Sci; 1993 Nov; 2(11):1959-65. PubMed ID: 8268805
[TBL] [Abstract][Full Text] [Related]
37. Asn-150 of Murine Erythroid 5-Aminolevulinate Synthase Modulates the Catalytic Balance between the Rates of the Reversible Reaction.
Stojanovski BM; Ferreira GC
J Biol Chem; 2015 Dec; 290(52):30750-61. PubMed ID: 26511319
[TBL] [Abstract][Full Text] [Related]
38. Erythroid 5-aminolevulinate synthase and X-linked sideroblastic anemia.
Ferreira GC
J Fla Med Assoc; 1993 Jul; 80(7):481-3. PubMed ID: 8089650
[TBL] [Abstract][Full Text] [Related]
39. Effect of 5-aminolevulinic acid on erythropoiesis: a preclinical in vitro characterization for the treatment of congenital sideroblastic anemia.
Fujiwara T; Okamoto K; Niikuni R; Takahashi K; Okitsu Y; Fukuhara N; Onishi Y; Ishizawa K; Ichinohasama R; Nakamura Y; Nakajima M; Tanaka T; Harigae H
Biochem Biophys Res Commun; 2014 Nov; 454(1):102-8. PubMed ID: 25450364
[TBL] [Abstract][Full Text] [Related]
40. Pyridoxine refractory X-linked sideroblastic anemia caused by a point mutation in the erythroid 5-aminolevulinate synthase gene.
Furuyama K; Fujita H; Nagai T; Yomogida K; Munakata H; Kondo M; Kimura A; Kuramoto A; Hayashi N; Yamamoto M
Blood; 1997 Jul; 90(2):822-30. PubMed ID: 9226183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
